Changeflow GovPing Banking & Finance BaFin Warns Equity Research Ventures PTE. LTD. ...
Urgent Notice Added Final

BaFin Warns Equity Research Ventures PTE. LTD. - No Prospectus

Favicon for www.bafin.de BaFin News & Warnings
Published March 13th, 2026
Detected March 16th, 2026
Email

Summary

BaFin has issued a warning regarding Equity Research Ventures PTE. LTD. for offering capital investments in Germany without a required prospectus. The company is purportedly based in Singapore and is offering investments under the name "Co-Investment AlleAktien Wealth x SpaceX".

What changed

BaFin has identified evidence that Equity Research Ventures PTE. LTD. is offering capital investments to the public in Germany without publishing an approved prospectus, which is a legal requirement. The investments, marketed as "Co-Investment AlleAktien Wealth x SpaceX," are being advertised on specific websites. BaFin has found no indication that exemptions from the prospectus requirement apply, and emphasizes that an approved prospectus is mandatory for public offerings of capital investments in Germany.

Regulated entities and investors should be aware that this company is operating without the necessary regulatory approval for its offerings in Germany. BaFin encourages individuals with specific information about the offeror, such as contract templates or contact details, to report it to their whistleblower contact point. This notice serves as a warning to potential investors and highlights BaFin's enforcement of prospectus requirements.

What to do next

  1. Review investment offerings from Equity Research Ventures PTE. LTD. for compliance with German prospectus requirements.
  2. Report any relevant information regarding Equity Research Ventures PTE. LTD. to BaFin's whistleblower contact point.

Source document (simplified)

Erscheinung: 13.03.2026 | Topic Consumer protection, Prospectuses Equity Research Ventures PTE. LTD. („AlleAktien“): evidence indicates no prospectus published

The Federal Financial Supervisory Authority (BaFin) has evidence indicating that Equity Research Ventures PTE. LTD., purportedly domiciled in Singapore, is offering capital investments under the name “ Co -Investment AlleAktien Wealth x SpaceX” to the public in Germany without the required prospectus. These capital investments are being offered in the form of “other capital investments” within the meaning of section 1 (2) no. 7 of the German Capital Investment Act (Vermögensanlagengesetz – VermAnlG) on the websites go.alleaktien(.)com/spacex, wealth.alleaktien(.)com/spacex and bettermarkets(.)app/waitlist.

There are no indications that the conditions for exemption from the prospectus requirement are met.

Background:

In Germany, capital investments may be offered to the public only if an associated prospectus has already been approved by BaFin. During the approval process, BaFin checks whether the minimum information required by law is included in the prospectus and whether its content is understandable, coherent and consistent. However, BaFin does not check whether the information contained in the prospectus is correct. Moreover, it does not check whether the issuer is reliable nor does it examine the product in question. Issuers of capital investments must ensure that this is clearly indicated in their prospectuses. The issuers are liable for the accuracy of the information contained in the prospectus.

You can check whether an approved prospectus for offers of capital investments to the public has been filed with BaFin by consulting the database Prospectuses filed on the BaFin website.

Please note:

BaFin performs its functions and exercises its powers exclusively in the public interest in accordance with section 4 (4) of the Act Establishing the Federal Financial Supervisory Authority (Finanzdienstleistungsaufsichtsgesetz – FinDAG). Due to their statutory obligation of confidentiality, BaFin ’s staff are not in a position to provide third parties with information regarding the progress and results of administrative proceedings.

However, there are ways in which you can support BaFin ’s work: if you have any specific information about the offeror mentioned above – such as contract templates, email addresses, telephone or fax numbers of contact persons or the offeror’s account details – please do not hesitate to get in touch with our contact point for whistleblowers.

Did you find this article helpful?

We appreciate your feedback Your feedback helps us to continuously improve the website and to keep it up to date. If you have any questions and would like us to contact you, please use our contact form. Please send any disclosures about actual or suspected violations of supervisory provisions to our contact point for whistleblowers.

We appreciate your feedback helpful less helpful Comment (max. 1000 characters): * Mandatory field

Navigation

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
BaFin
Published
March 13th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Investors
Geographic scope
Germany

Taxonomy

Primary area
Financial Services
Operational domain
Compliance
Topics
Consumer Protection Securities

Get Banking & Finance alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when BaFin News & Warnings publishes new changes.

Free. Unsubscribe anytime.